Wafaa E. Soliman
Impact in
- Drug Discovery top 5%
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
Papers in
-
- Advancements in Transdermal Drug Delivery 14
- Drug Solubulity and Delivery Systems 1
-
- Antimicrobial Resistance in Staphylococcus 3
- Co-authors
- Heba S. Elsewedy (17 shared papers)Tamer M. Shehata (16 shared papers)Nancy S. Younis (5 shared papers)Maged E. Mohamed (4 shared papers)Dalia Ibrahim Mohamed (1 shared paper)Rasha Mosbah (2 shared papers)Maan Talaat Abdullah Khayat (2 shared papers)Tarek Salah Ibrahim (2 shared papers)
- Journals
- Gels (3 papers)Polymers (3 papers)Plants (2 papers)Nanomaterials (2 papers)Chemico-Biological Interactions (1 paper)
- Partner nations
- EgyptSaudi ArabiaIndia
In The Last Decade
Wafaa E. Soliman
32 papers receiving 642 citations
Peers
Comparison fields: 5 of 71
- Drug Discovery 10
- Pharmaceutical Science 217
- Rehabilitation 38
- Biomaterials 53
- Molecular Medicine 27
Countries citing papers authored by Wafaa E. Soliman
This map shows the geographic impact of Wafaa E. Soliman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wafaa E. Soliman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wafaa E. Soliman more than expected).
Fields of papers citing papers by Wafaa E. Soliman
This network shows the impact of papers produced by Wafaa E. Soliman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wafaa E. Soliman. The network helps show where Wafaa E. Soliman may publish in the future.
Co-authors
The 25 scholars most cited alongside Wafaa E. Soliman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 58 | |
| 2 | 2021 | 54 | |
| 3 | 2020 | 53 | |
| 4 | 2021 | 48 | |
| 5 | 2021 | 43 | |
| 6 | 2021 | 40 | |
| 7 | 2023 | 39 | |
| 8 | 2019 | 32 | |
| 9 | 2022 | 30 | |
| 10 | 2021 | 29 | |
| 11 | 2021 | 29 | |
| 12 | 2021 | 27 | |
| 13 | 2022 | 21 | |
| 14 | 2022 | 20 | |
| 15 | 2022 | 18 | |
| 16 | 2020 | 16 | |
| 17 | 2023 | 14 | |
| 18 | 2021 | 11 | |
| 19 | 2022 | 11 | |
| 20 | 2020 | 9 |
About Wafaa E. Soliman
Wafaa E. Soliman is a scholar working on Pharmaceutical Science, Infectious Diseases, Rehabilitation, Food Science and Pharmacology, having authored 33 papers that have together received 650 indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (14 papers), Bacterial biofilms and quorum sensing (4 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Nanoparticles: synthesis and applications (3 papers), Wound Healing and Treatments (2 papers), Essential Oils and Antimicrobial Activity (2 papers), Drug Solubulity and Delivery Systems (1 paper) and Steroid Chemistry and Biochemistry (1 paper). The work is most often cited by research in Drug Discovery (10 citations), Pharmaceutical Science (217 citations), Rehabilitation (38 citations), Biomaterials (53 citations) and Molecular Medicine (27 citations). Wafaa E. Soliman has collaborated with scholars based in Egypt, Saudi Arabia and India. Frequent co-authors include Heba S. Elsewedy, Tamer M. Shehata, Nancy S. Younis, Maged E. Mohamed, Dalia Ibrahim Mohamed, Rasha Mosbah, Maan Talaat Abdullah Khayat, Tarek Salah Ibrahim, Tamer Ahmed Ismail and Wael A. H. Hegazy. Their work appears in journals such as Gels, Polymers, Plants, Nanomaterials and Chemico-Biological Interactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.